Both copyright and Tirzepatide are effective medications helping people address obesity, but they operate through distinct mechanisms. copyright primarily influences glucagon-like peptide-1 (GLP-1) receptors, boosting insulin production and diminishing appetite . Tirzepatide , on the other hand, is a double receptor activator that stimulates both G